Involvement of phytochemical-encapsulated nanoparticles' interaction with cellular signalling in the amelioration of benign and malignant brain tumours

S Mehan, N Arora, S Bhalla, A Khan, MU Rehman… - Molecules, 2022 - mdpi.com
Brain tumours have unresolved challenges that include delay prognosis and lower patient
survival rate. The increased understanding of the molecular pathways underlying cancer …

[HTML][HTML] Highlights in targeted nanoparticles as a delivery strategy for glioma treatment

MT Luiz, LD Di Filippo, LB Tofani, JTC de Araújo… - International Journal of …, 2021 - Elsevier
Glioma is the most common type of Central Nervous System (CNS) neoplasia and it arises
from glial cells. As glial cells are formed by different types of cells, glioma can be classified …

Management of glioblastoma multiforme by phytochemicals: applications of nanoparticle-based targeted drug delivery system

SM Mumtaz, G Bhardwaj, S Goswami… - Current Drug …, 2021 - ingentaconnect.com
The Glioblastoma Multiforme (GBM; grade IV astrocytoma) exhorts tumors of star-shaped
glial cells in the brain. It is a fast-growing tumor that spreads to nearby brain regions …

Theranostic potential of targeted nanoparticles for brain cancer

A Bhatt, E Gurnany, A Modi… - Mini Reviews in …, 2017 - ingentaconnect.com
Cancer is one of the most important causes of morbidity and mortality all across the world.
On an average, every year approximately 238,000 new cases of brain and other central …

[PDF][PDF] Role of nanostructures and immunotherapies in management of glioblastoma multiforme: current perspectives and challenges

MS Trivedi - Asian Journal of Pharmaceutics (AJP), 2021 - asiapharmaceutics.info
Glioblastoma Multiforme (GBM), a highly infiltrative grade IV primary malignant brain tumor,
is characterized by poor prognosis which ultimately leads to a high mortality rate. Various …

[HTML][HTML] Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme

P Tagde, P Tagde, S Tagde, T Bhattacharya… - Biomedicine & …, 2021 - Elsevier
Glioblastoma multiforme is one of the most deadly malignant tumors, with more than 10,000
cases recorded annually in the United States. Various clinical analyses and studies show …

The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma

P Allami, A Heidari, N Rezaei - Frontiers in Molecular Biosciences, 2023 - frontiersin.org
Glioblastoma multiform (GBM) is the most prevalent and deadliest primary brain malignancy
in adults, whose median survival rate does not exceed 15 months after diagnosis. The …

Delivery of nanoparticles for treatment of brain tumor

C Kang, Y Sun, J Zhu, W Li, A Zhang… - Current Drug …, 2016 - ingentaconnect.com
Background: Malignant brain tumor is a highly challenging disease for diagnosis, treatment,
and management. Cytotoxicity, distribution and the ability to cross blood brain barrier are …

Effective treatment of glioblastoma requires crossing the blood–brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine

SS Kim, JB Harford, KF Pirollo, EH Chang - Biochemical and biophysical …, 2015 - Elsevier
Glioblastoma multiforme (GBM) is the most aggressive and lethal type of brain tumor. Both
therapeutic resistance and restricted permeation of drugs across the blood–brain barrier …

Recent advances in nanoparticle-based approaches for the treatment of brain tumors: Opportunities and challenges

J Ahamed, BHJ Gowda, WH Almalki, N Gupta… - European Polymer …, 2023 - Elsevier
Malignant brain tumors remain to be highly fatal illnesses with a bleak outlook, as the
average survival rate for patients after receiving medical treatment is less than two years …